Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label PK study of aripiprazole IM depot in schizophrenia
jRCT2080221487Phase 3
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of aripiprazole in schizophrenia, sponsored by Otsuka Pharmaceutical Co., Ltd.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on jRCT2080221487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221487.